Guest guest Posted May 23, 2007 Report Share Posted May 23, 2007 Guidelines for Therapy of Autoimmune Liver Disease Hiromi Ishibashi, Atsumasa Komor, Shinji Shimoda, M. Gershwin Clinical Research Center, National Hospital Organization (NHO), Nagasaki Medical Center, and Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan Division of Rheumatology, Allergy, and Clinical Immunology, University of California at School of Medicine, Genome and Biomedical Sciences Facility, , California ABSTRACT The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. Treatment of this autoimmune liver disease should also address various symptoms and complications arising from any associated autoimmune diseases, particularly cholestasis and cirrhosis-related complications. For primary sclerosing cholangitis there are no established immunomodulatory therapies, but medical, endoscopic, and surgical treatments are applicable to this disease. Liver transplantation becomes indicated during the eventual end stages of each of these immune-mediated liver diseases. Barb in Texas - Together in the Fight, Whatever it Takes! Son Ken (33) UC 91 - PSC 99 Listed 7/21 @ Baylor Dallas Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 23, 2007 Report Share Posted May 23, 2007 Thanks for posting this Barb.Doesn't it make you mad to see that treatment for AH is steroids, treatment for PBC is URSO and for PSC "there are no established immunomodulatory therapies" ?To quote Huey , "I want a new drug"!!One to treat PSC !Dang, we need that research.Thanks for keeping us up on things,LeePS Best wishes for Ken , I am thinking about your family.For primary sclerosing cholangitis there are no established immunomodulatory therapies, but medical,endoscopic, and surgical treatments are applicable to this disease. Liver transplantation becomes indicated during the eventual end stages of each of these immune-mediated liver diseases.Barb in Texas - Together in the Fight, Whatever it Takes!Son Ken (33) UC 91 - PSC 99 Listed 7/21 @ Baylor Dallas Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.